Schedule 13G ownership disclosure
XTL BIOPHARMACEUTICALS LTD
Security class unavailable · CUSIP: 98386D109
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 437,968
- Percent of class
- 3.1900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-17-000019
- Form type
- SC 13G
- Filer
- SABBY MANAGEMENT, LLC
- CIK
- CIK 1535610
- Filed
- Jan 06, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership